UPLC/MS for the identification of beta-blockers

Stephen A C Wren1, Pierre Tchelitcheff

  • 1Analytical Development, PAR&D, AstraZeneca, Silk Business Park, Macclesfield, Cheshire SK10 2NA, UK. stephen.wren@astrazeneca.com